Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 242Lung Neoplasms 59Neoplasms 57Head and Neck Neoplasms 57Stomach Neoplasms 56Squamous Cell Carcinoma of Head and Neck 48Parkinson Disease 4, Autosomal Dominant Lewy Body 44Neoplasm Metastasis 40Small Cell Lung Carcinoma 38Urinary Bladder Neoplasms 28Uterine Cervical Neoplasms 26Esophageal Neoplasms 25Colorectal Neoplasms 24Cholangiocarcinoma 24Biliary Tract Neoplasms 24Carcinoma 23Ovarian Neoplasms 21Carcinoma, Transitional Cell 18Carcinoma, Squamous Cell 17Recurrence 16Esophageal Squamous Cell Carcinoma 16Melanoma 13Breast Neoplasms 13Non-Squamous Non-Small Cell Lung Cancer 12Mesothelioma, Malignant 12Mesothelioma 12Nasopharyngeal Carcinoma 11Endometrial Neoplasms 11Adenocarcinoma 11Gallbladder Neoplasms 10

Interventions

Irinotecan 4Fluorouracil 4Bevacizumab 4Oxaliplatin 3Leucovorin 3Drug Therapy 35,10-methylenetetrahydrofolic acid 3Ocoxin 2Levoleucovorin 2Folfox protocol 2sintilimab 1repotrectinib 1pralsetinib 1pembrolizumab 1napabucasin 1golotimod 1encorafenib 1alectinib 1S-1 plus cisplatin 1Radiotherapy 1Pharmaceutical Preparations 1Pemetrexed 1Paclitaxel 1KRN-330 1Imatinib Mesylate 1IDRX-42 1Cisplatin 1Cetuximab 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Gastrointestinal Diseases × Cisplatin × Clear all
NCT03748134 2023-10-24

Sintilimab or Placebo With Chemotherapy in Esophageal Squamous Cell Carcinoma ( ORIENT-15 )

Innovent Biologics (Suzhou) Co. Ltd.

Phase 3 Completed
746 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma, Carcinoma, Squamous Cell, Esophageal Diseases, Esophageal Neoplasms, Gastrointestinal Diseases, Neoplasms, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡